Published in Lancet on June 17, 1989
Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science (2003) 11.39
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes (2009) 8.70
Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal (2013) 1.60
Impaired glucose tolerance. BMJ (1990) 1.60
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes (2009) 1.54
Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study. Diabetes Care (2009) 1.40
Hypertension and non-insulin dependent diabetes. BMJ (1991) 1.25
Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care (2013) 1.19
Insulin resistance and hyperinsulinemia: you can't have one without the other. Diabetes Care (2008) 0.99
The pathogenesis of NIDDM. Diabetologia (1994) 0.90
The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects. Korean Diabetes J (2010) 0.89
Insulin resistance: Is it time for primary prevention? World J Cardiol (2012) 0.85
Patterns and predictors of long-term glycemic control in patients with type 2 diabetes. ISRN Endocrinol (2012) 0.83
Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts. J Biol Chem (2014) 0.83
Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes. Vasc Health Risk Manag (2007) 0.82
Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide. J Diabetes Investig (2013) 0.78
Glucose supply and insulin demand dynamics of antidiabetic agents. J Diabetes Sci Technol (2010) 0.76
The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis. Postgrad Med J (1991) 0.75
Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? J Intern Med (2016) 0.75
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96
The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care (2000) 7.41
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest (1999) 7.35
Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet (1988) 7.00
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr (2000) 6.82
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes (2000) 5.83
Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ (1994) 5.22
Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22
Amerindian mitochondrial DNAs have rare Asian mutations at high frequencies, suggesting they derived from four primary maternal lineages. Am J Hum Genet (1990) 5.17
Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med (1996) 5.17
Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes (1987) 4.86
Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83
Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics (1992) 4.78
Dramatic founder effects in Amerindian mitochondrial DNAs. Am J Phys Anthropol (1985) 4.56
Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care (1990) 4.49
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87
Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev (1990) 3.64
Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care (1991) 3.51
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet (1998) 3.37
The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med (1988) 3.36
Diabetes mellitus in American (Pima) Indians. Lancet (1971) 3.30
Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med (1988) 3.19
An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet (1998) 3.16
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01
Identification of a small RNA containing the trypanosome spliced leader: a donor of shared 5' sequences of trypanosomatid mRNAs? Cell (1984) 3.01
Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes (1988) 3.00
Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol (1981) 2.97
Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products. Infect Immun (2000) 2.92
Gestational diabetes mellitus. JAMA (2001) 2.90
Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ (1994) 2.67
Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet (1980) 2.64
Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med (1983) 2.60
Increasing prevalence of Type II diabetes in American Indian children. Diabetologia (1998) 2.57
Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia (1999) 2.55
Sequences homologous to the variant antigen mRNA spliced leader are located in tandem repeats and variable orphons in trypanosoma brucei. Cell (1983) 2.53
Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence. FEMS Microbiol Lett (1996) 2.53
Body mass index as a measure of adiposity in children and adolescents: relationship to adiposity by dual energy x-ray absorptiometry and to cardiovascular risk factors. J Clin Endocrinol Metab (2001) 2.52
Isolation, sequence and molecular karyotype analysis of the actin gene of Cryptosporidium parvum. Mol Biochem Parasitol (1992) 2.50
Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet (1997) 2.45
Trypanosome mRNAs share a common 5' spliced leader sequence. Cell (1984) 2.43
Is a low leptin concentration, a low resting metabolic rate, or both the expression of the "thrifty genotype"? Results from Mexican Pima Indians. Am J Clin Nutr (1998) 2.42
Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med (1980) 2.37
Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr (2004) 2.25
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest (1998) 2.18
Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med (1970) 2.16
Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care (1994) 2.15
Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care (2000) 2.14
Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care (1980) 2.12
GM allotypes in Native Americans: evidence for three distinct migrations across the Bering land bridge. Am J Phys Anthropol (1985) 2.11